DIVIS LABORATORIES
Back to All Ratios
|
DIVIS LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 97.85 | 74.64 | 81.77 | 123.26 | 84.38 |
What is the latest Cash Earnings per Share (CEPS) ratio of DIVIS LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 97.85 |
| Mar2024 | 74.64 |
| Mar2023 | 81.77 |
| Mar2022 | 123.26 |
| Mar2021 | 84.38 |
How is Cash Earnings per Share (CEPS) of DIVIS LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 97.85 | 31.10 | |
| Mar2024 | 74.64 | -8.72 | |
| Mar2023 | 81.77 | -33.66 | |
| Mar2022 | 123.26 | 46.08 | |
| Mar2021 | 84.38 | - | |
Other Financial Ratios of DIVIS LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of DIVIS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DIVIS LABORATORIES | ₹155,300.2 Cr | -1.6% | -7.2% | 0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,326.0 Cr | -2.2% | -1.8% | -2.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,043.0 Cr | -4.1% | -6.7% | 23.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,854.2 Cr | -4.7% | -7.3% | 6.4% | Stock Analytics | |
| CIPLA | ₹97,115.7 Cr | -1.7% | -8.4% | -16.7% | Stock Analytics | |
| MANKIND PHARMA | ₹84,231.4 Cr | 1.7% | -7.5% | -16.7% | Stock Analytics | |
DIVIS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DIVIS LABORATORIES | -1.6% |
-7.2% |
0.6% |
| SENSEX | 1.4% |
-7% |
-3.9% |
You may also like the below Video Courses